期刊文献+

HIV整合酶抑制剂体外筛选方法研究进展 被引量:1

The Methods for Screening HIV Integrase Inhibitors in vitro
下载PDF
导出
摘要 为了评价HIV整合酶抑制剂体外筛选方法的特点和整合酶抑制剂研究进展,以常用的3′加工反应法、链转移反应法、改良ELISA法及基于结构的筛选为基础归类整合酶抑制剂。整合酶抑制剂按方法分为五类,并可推测其作用机制,通过比较可知以上方法各有利弊,需配合运用。整合酶抑制剂有研究价值。 The advantages and characteristic of the methods for screening HIV integrase inhibitors in vitro and the development of integrase inhibitors were evaluated. Through particularizing method such as 3' process reaction, chain transfer reaction, improved ELISA, and screening inhibitors based on structure, HIV integrase inhibitors were classified. HIV integrase inhibitors can be divided into five species and used to speculate their mechanisms. All these methods should be cooperatively applied, and inh.ibitors have a research value.
出处 《药物生物技术》 CAS CSCD 2007年第1期68-70,共3页 Pharmaceutical Biotechnology
基金 云南省应用基础研究基金资助(NO.2006C0046M)
关键词 HIV整合酶 整合酶抑制剂 筛选方法 HIV integrase, Integrase inhibitor , Screening methods
  • 相关文献

参考文献18

  • 1Pani A,Marongiu ME.Anti-HIV-1 integrase drugs:how far from the shelf[J].Curr Pharm Des,2002,6:569.
  • 2Nick S,Sachindra SP,Sonja H,et al.Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry[J].PNAS,2004,101:6894.
  • 3Wenjie T,Kai Z,David JS,et al.Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites[J].JVI,2004,78(3):1301.
  • 4Elena B,Jonathan L.HIV-1 Integrase Interaction with U3 and U5 Terminal Sequences in vitro Defined Using Substrates with Random Sequences[J].JBC,2002,277 (21):18357.
  • 5Julia A,Maksim S,Evgeni Z,et al.HIV-1 integrase can process a 3'-end crosslinked substrate[J].FEBS,2004,271:205.
  • 6Aur lie F,Christina C,Cecile D,et al.HIV-1 integrase crosslinked oligomers are active in vitro[J].Nucleic Acids Research,2005,33(3):977.
  • 7Young H,Denise R,Frederic B.Rapid microtiter assays for poxvirus topoisomerase,mamm alian type IB topoisomerase and HIV-1 integrase:application to inhibitor isolation[J].Nucleic Acids Res,2000,28:4884.
  • 8Kui G,Steven W,Frederic B.Metal Binding by the D,DX35E Motif of Human Immuno-deficiency Virus Type 1 Integrase Selective Rescue of Cys Substitutions by Mn2+ in vitro[J].JVI,2004,78(13):6715.
  • 9Christophe M,Zhang XC,Godwin CGP,et al.Structural Determinants for HIV-1 Integrase Inhibition by β-Diketo Acids[J].J Biol Chem,2002,277:12596.
  • 10Christophe M,Allison AJ,Rajeshri GK,et al.MetalDependent Inhibition of HIV-1 Integrase by β-Diketo Acids and Resistance of the Soluble Double-Mutant (F185K/C280S)[J].Molecular Pharmacology,2003,64:600.

二级参考文献8

  • 1Jenkins TM,Engelman A,Ghirlando R,et al.A soluble active mutant of HIV-1 integrase involvement of both the core and carboxyl-terminal domains in multimerization[].Journal of Biological Chemistry.1996
  • 2Hazuda DJ,Hastings JC,Wolfe AL,et al.A novel assay for the DNA strand-transfer reaction of HIV-1 integrase[].Nucleic Acids Research.1994
  • 3Engelman A,Craigie R.Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity[].Journal of Virology.1995
  • 4Reasmussen SR,Ravnlaisen M,Rasmussen SE,et al.Covalent immobilization of DNA onto polystyrene microwells: the molecules are only bound at the 5′end[].Analytical Biochemistry.1991
  • 5Ansubel F,Brerd R,Kingston RE,et al.Short protocols in molecular biology.In: John wiley, Sons, eds. 3rd ed[].New York.1997
  • 6Jing N,Clercq ED,Rando RF,et al.Stability-activity relationship of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors[].Journal of Biological Chemistry.2000
  • 7Hazuda D,Felock PJ,Hastings JC,et al.Discovery and analysis of inhibitor of the human immuodeficiency integrase[].Drug Design and Discovery.1997
  • 8Pani A,Marongiu ME.Anti-HIV-1 integrase drugs: how far from the shelf[].Current Pharmaceutical Design.2000

共引文献5

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部